Daily Financial Update
Opening Recap
Market Pulse: Biotech lit a fuse as Johnson & Johnson scored FDA approval for INLEXZO, sparking a surge in drugmakers. Banking jitters hit Teck Resources when Bank of America yanked its rating. MYX’s monumental short squeeze and fresh Fed rate-cut whispers sent crypto on a roller-coaster.
Key Movers: Johnson & Johnson’s INLEXZO thumbs-up (Thefly.com) and Teck’s rating removal (Thefly.com) stole headlines, while MYX short sellers faced over $40 million liquidated (Biztoc.com, CoinDesk).
Macro & Politics: Rate-cut speculation keeps crypto apes moon-bound until policymakers remind everyone who really holds the punch bowl. Overseas, Indian startups showcased to global investors at the Commonwealth Fellowship (The Times of India).
What’s Next: Watch for Fed remarks and S&P breadth tests at today’s open.
Unfiltered Market Commentary
Everyone’s chasing the FDA pop with INLEXZO as if every green light in pharma signals lasting gains—what’s missing is the attrition rate once the buzz fades. Johnson & Johnson’s victory (Thefly.com) will have bulls scrambling for biotech exposure, but every approval rarely sustains momentum beyond the first fucking rush.
On the heels of Kepler-level squeeze in MYX (Coindesk, Biztoc.com), traders are diving into tokens like SPX6900 and Bitcoin on Fed cut daydreams (Cointelegraph) as if valuation never mattered. One minute you’re riding forced liquidations, the next you’re praying for central banks to shave rates—prime recipe for whipsaw drama when reality bites.
If you’re banking on a merger fairy tale for Teck Resources (Thefly.com) or hitching to robotaxi hype, tighten your stops and carve out hedges. Check the lack of breadth in US Stocks Pare Gains (Financial Post)—this rally could stall fast. My takeaway: trim euphoric positions, stash dry powder, and play defense until the market shows its hand.
📈 Breaking Financial News
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Traders speculating on MYX Finance's native token (MYX) were in for a rude awakening this week, with more than $40 million being liquidated over the past 24 hours as the shadowy project continued its surge from $0.10 to $16 over the past 60 days.
Crypto analy…
MYX’s token has surged from 10 cents to $16 in just two months, triggering $40 million in liquidations and raising red flags over liquidity and valuation.
US equities pared gains on Monday as a rally in tech shares couldn’t offset declines in other industries, even as traders continue to bet that a Federal Reserve interest rate cut will fuel further stock market gains.
ELON MUSK IS ABOUT TO MAKE TESLA SKEPTICS LOOK LIKE COMPLETE IDIOTS… AGAIN
Remember when “experts” said Tesla would never work? That electric cars were a joke? That Elon was just a “crazy dreamer”? Those same morons are now saying robotaxis are “decades away.” WRONG. Tesla's robotaxi fleet launches THIS YEAR. The $34 trillion revolution starts NOW. Marc Lichtenfeld reveals his thoughts on which companies will ride Elon's coattails to massive profits. Don't be the fool who bets against Musk AGAIN
🔍 Market Analysis & Insights
Apple launched the iPhone 17, iPhone Air, and redesigned the Pro and Pro Max models. Plus, they unveiled the AirPods Pro 3 and Apple Watch 11.
Apple just announced its new watch lineup: the Series 11, Ultra 3, and SE (2025). Here’s what’s new and when you can buy them.
MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) — Celcuity Inc. (“Celcuity”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it has entered into an amendment to its existing senior secured cr…
Three Indian startups showcased their innovations to investors in London. These startups were selected for the Commonwealth Startup Fellowship. The fellowship is a UK government-funded program. Lifeandlimb.ai, Hexpressions, and AgrowSure represented India. Th…
The Anxiety Disorders and Depression Treatment Market is poised for significant growth, escalating from USD 20.51 billion in 2024 to USD 34.31 billion by 2033, driven by rising mental health awareness, global stress levels, and advancements in therapies. Incr…
The Liquidity Engine Powering Crypto's Comeback
The post-tariff crypto boom is underway, and one liquidity protocol sits at the absolute center of this market-wide explosion. Institutional capital is flooding in while most investors remain completely unaware – creating what could be the buying opportunity of a lifetime. Exposed: Crypto's liquidity backbone set for massive gains – get all details for just $3!
💰 Investment Opportunities
The Southern California Biomedical Council (SoCalBio) kicks off its 27th Investor & Partnership Conference on October 1 at the Hyatt Regency Newport Beach
BTC price strength starts to convince traders that new highs are back on the table, but Bitcoin still needs spot-market support.
Whales dominated SPX’s surge, but will hidden liquidity zones spark a reversal?
Opendoor Technologies experienced a roller coaster Monday that perfectly illustrates why the real estate technology company has become one of Wall Street’s most unpredictable investments, leaving both seasoned investors and amateur traders scrambling to under…
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that it…
The Cross-Chain Giant Set for 1,000%+ Gains
As crypto markets surge post-tariffs, one multi-chain financial protocol is being targeted for massive institutional investment before retail discovers it. Its transaction volume is skyrocketing across all major blockchains while its price remains suppressed as retail has yet to discover it – creating a coiled spring ready to release. Breaking: Access our urgent research on this cross-chain opportunity for just $3!